Schedule 13G ownership disclosure
Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.)
Security class unavailable · CUSIP: 03835T101
Event date: 2015-01-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-008597
- Form type
- SC 13G
- Filer
- Aptose Biosciences Inc.
- CIK
- CIK 882361
- Filed
- Feb 13, 2015
- Reporting period
- Jan 27, 2015
- Description
- Schedule 13G beneficial ownership